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Summary
Objective: To prepare, sequence and analyse adult human cartilage cDNA libraries to study the gene expression pattern between normal and
osteoarthritic cartilage.
Methods: Poly A+ RNA from adult human normal and osteoarthritic articular cartilage was isolated and used to prepare cDNA libraries.
Approximately 5000 ESTs from each library were sequenced and analysed using bioinformatic tools. The expression of select genes was
confirmed by Northern blot and in situ hybridization analysis.
Results: Multiple gene families including several classical cartilage matrix protein encoding genes were identified. Approximately 28–40% of
the genes sequenced from these libraries were novel, while half of the genes encoded known proteins and 4–6% of the genes encoded novel
homologs of known proteins. Several known genes, whose expression has not been reported previously in cartilage, were also identified. We
have confirmed the cartilage expression of three known (CTGF, CTGF-L and clusterin) and two novel homologs of known genes (PCPE-2
and Gal-Nac transferase) by Northern blot and in situ hybridization analysis.
Conclusion: This is the first report of the preparation and sequencing of cDNA libraries from adult human normal and osteoarthritic articular
cartilage. Further analysis of genes identified from these libraries may provide molecular targets for diagnosis and/or treatment of
osteoarthritis (OA). © 2001 OsteoArthritis Research Society International
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Osteoarthritis (OA) is a debilitating joint disease that may
occur in up to ∼9% of the adult population1. This disease is
treated with compounds that control pain and/or inflamma-
tion; however, there are currently no effective disease-
modifying therapies available to treat this condition.
Although there has been significant effort applied to identi-
fication of biochemical markers to diagnose and monitor
disease progression, a clearly validated marker awaits
identification2. Analysis of differential gene expression
between non-diseased and osteoarthritic cartilage is one
approach to identify genes that may be novel therapeutic
targets and/or robust diagnostic or prognostic tools. Over
the past 20 years, significant effort has been applied to
identification of articular cartilage matrix components. The
majority of these studies have focused on the biochemical641identity of these components upon extraction from articular
cartilage. The difficulty with this approach is that proteins
that are less abundant, or that have relatively short half-
lives within the tissue, may have been missed through
biochemical characterization. Recently, newly synthesized
matrix components have been identified using in vitro
radiolabeling and biochemical characterization3,4. This has
allowed for the identification of matrix components that are
less abundant but which are actively being produced at the
time of tissue isolation. In addition to examining the pro-
teins residing within cartilage, recent efforts have focused
on identification and characterization of transcripts which
encode these proteins5,6. Changes in expression of key
matrix genes have been observed upon cytokine treat-
ment7 and mechanical loading of cartilage explants8. The
limitation with this approach is that only known genes can
be monitored.
An alternative approach to identify expressed genes is
through high throughput sequencing of cDNA libraries
prepared from tissues of interest. This has been difficult to
achieve with articular cartilage since there is a paucity of
well-characterized tissue. Moreover, isolation of high
quality RNA from this tissue is complicated by the complex,
highly charged extracellular matrix and presence of rela-
tively small number of chondrocytes. Recently, a cDNA
library was prepared from RNA isolated from mouse growth
plate cartilage9. The gene expression pattern identified
from sequencing of this library was consistent with some of
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TISSUE
Human osteoarthritic cartilage was obtained with
informed consent and with the approval of the institutional
review board from patients undergoing knee replacement
surgery (Pennsylvania Hospital, Philadelphia, PA) for OA.
Control normal as well as osteoarthritic cartilage was
obtained at the time of autopsy through the Anatomical Gift
Foundation (Laurel, MD). The disease state of the cartilage
was characterized by the following histological criteria: (a)
normal cartilage had a smooth, intact superficial zone
and no indication of proteoglycan loss (as determined by
toluidine blue staining) from the mid- or deep zones; (b)
early OA damage included slight fissuring of the superficial
zone and loss of proteoglycan from the zones immediately
surrounding the chondrocytes in the mid- and deep zones;
(c) advanced OA cartilage included deep and extensive
fissuring of the superficial zone with characteristic cloning
of chondrocytes and extensive proteoglycan loss through-
out the mid- and deep zones. All articular cartilage tissue
was removed from the surface of the joints while avoiding
subchondral bone, osteophytes and reparative tissues.
Due to the limited amount of tissue available from each
patient sample and the relatively low concentration of RNA
in cartilage, RNA samples were pooled where necessary to
provide the required quantities of RNA for the various
analyses described in the following sections. The distinct
and specific composition of each RNA sample is described
in the appropriate sections below.TOTAL RNA EXTRACTION AND PURIFICATION
Total RNA from human cartilage was extracted by a
modified method of Adams et al.10, as follows. Fresh
cartilage tissue was frozen immediately in liquid nitrogen
and stored at −80°C prior to extraction. Frozen cartilage
(0.5–1.0 g) was powdered in a Spex Freezer Mill
(SPEX, Metuchen, NJ) and immediately homogenized in
4 ml of 4 M guanidinium isothiocyanate solution (Life
Technologies, Gaithersburg, MD) with 2.5 l of 2-
mercaptoethanol. The extracts were centrifuged at 1500×g
for 10 min at 4°C and the supernatant was transferred to a
separate tube. The extraction of the pellet was repeated
and the supernatants were pooled. Triton X-100 (0.65 ml of
25%) was added to the supernatants, which were mixedand incubated on ice for 15 min. Sodium acetate (8.0 ml of
3 M at pH 6.0) was added, mixed and incubated on ice for
15 min. The supernatants were extracted with 12 ml phenol
(DEPC-water saturated; acidic) and 3 ml chloroform/
isoamyl alcohol (49:1), mixed and incubated on ice for
10 min, then centrifuged at 15,000×g for 20 min. The
extraction and separation of the aqueous phase was
repeated twice with 10 ml phenol and 10 ml chloroform/
isoamyl alcohol (49:1). The RNA in the aqueous phase was
precipitated with 0.8 volumes of isopropanol on ice for
5 min followed by centrifugation at 15,000×g for 30 min.
The RNA was further purified by Qiagen RNeasy kit
(Qiagen, Chatsworth, CA). The concentration and purity of
the RNA were determined by spectrophotometric analysis
and structural integrity was confirmed by agarose gel
electrophoresis.CDNA LIBRARY CONSTRUCTION AND SEQUENCING
Total RNA from normal (three patients) or osteoarthritic
(five patients) cartilage was used to generate Poly A+
mRNA and high-quality directional cDNA libraries in
pSPORT 1 vector (BioServe Technologies Inc., Laurel,
MD). Bacterial clones were grown on agar plates and
colonies were picked by Q-Bot robot (Genetix Ltd,
Christchurch, U.K.). Template DNA for sequencing was
prepared using a Biorobot 9600 (Qiagen, Valencia, CA).
Approximately 5000 clones were sequenced from each
library using an Applied Biosystems 377 automated DNA
sequencer with a 5′ vector specific primer and BigDye
terminator chemistry (Applied Biosystems, Foster City, CA).
Due to the directional nature of the libraries, sequencing
was performed from the 5′ end to generate cDNA
sequences corresponding to the 5′ UTR and coding
regions.ANALYSIS OF ESTS
For each library, the EST sequences were subjected to
an assembly process whereby overlapping EST sequences
(presumably belonging to the same genes) were joined into
extended contiguous sequences (assemblies). The first
step of the assembly process involved trimming of unin-
formative regions such as vector and polylinker sequences,
regions of low quality sequence, Alu and other repeats, and
poly-A regions. In the next step, such trimmed EST
sequences, along with all other EST sequences derived
from other sources (public and proprietary), were joined
into contiguous assemblies subject to the condition that
the ESTs shared an overlapping region of at least forty
nucleotides with 90% or better identity. ESTs belonging to
an assembly correspond to a different part of the same
cDNA and an assembly, therefore, can be considered as a
virtual cDNA. Characterization and annotation of the
assemblies were achieved by sequence comparison to
other known proteins, and supplemented by signature motif
searches of known protein families using BLAST and
proprietary algorithms. Assemblies with >95% identity
over 50 bases were considered known whereas those
with significant similarity (BLAST P-value ≤1×10−6) to
known genes were considered potential novel homologs.
Assemblies with no similarity (BLAST P-value >1×10−6) to
any known genes were considered unknown.NORTHERN BLOT ANALYSIS
Cells were isolated in-house or obtained from ATCC
(Manassas, VA) and maintained in appropriate mediumthe biochemical analysis previously reported for this tissue.
However, cDNA libraries derived from human articular
cartilage have not been described previously. In this manu-
script, we report the expression patterns obtained through
sequencing of approximately 5000 expressed sequence
tags (ESTs) from each cDNA libraries prepared from
human control normal and osteoarthritic cartilage. Several
classical cartilage associated matrix genes were identified
through this approach. In addition, the expression of sev-
eral known genes, previously not identified within cartilage,
are described. A number of novel homologs of known
genes were also identified. Lastly, there are a large number
of sequences, which correspond to as yet unidentified
genes. Together these data suggest that there is a large
diversity of genes that remain to be fully characterized
within human articular cartilage. Examination of expression
patterns of these genes and further analysis may assist in
identification of their function within articular cartilage.
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various cells and tissues using Trizol reagent (Life
Technologies Inc., Rockville, MD) according to the manu-
facturer’s recommendations. Cartilage RNA from individual
patient samples not previously represented in the cDNA
library preparations was isolated as described in the pre-
vious section. RNA was fractionated by electrophoresis
on 1.2% agarose-formaldehyde gels, transferred to
Genescreen plus membranes and cross-linked using an
UV Stratalinker-180 (Stratagene, La Jolla, CA). The blots
were probed with 32[P]-labeled cDNAs and the housekeep-
ing gene glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) according to standard procedures. A commercial
human multiple tissue Northern blot (Clontech, Palo Alto,
CA) containing 2 g of poly A+ RNA from various
tissues was processed according to the manufacturer’s
instructions.Fig. 1. Analysis of insert size of normal and OA cDNA library. Nineteen random bacterial clones from normal (top) and osteoarthritic (bottom)
cDNA libraries were picked and grown. The plasmid DNA was isolated and insert liberated by digestion with NotI and SalI. The digest was
electrophoresed through an agarose gel, stained with ethidium bromide and photographed. The location of pSPORTI vector and the inserts
as well as the molecular weight markers (M) in kilobases (Kb) are indicated.Table I
Analysis of ESTs generated from high throughput sequencing of normal and osteoarthritic human adult cartilage
cDNA libraries
Library ESTs/ESTs
assembled
(%)
Assembly
number
Known
(%)
Novel
homolog
(%)
Unknown
(%)
Normal cartilage 5226/4415
(85%)
2819 1590
(56%)
119
(4%)
1110
(40%)
Osteoarthritic cartilage 5023/4085
(81%)
2337 1572
(66%)
139
(6%)
666
(28%)IN SITU HYBRIDIZATION
Preparation of cryostat sections (5 m) of unfixed, unde-
calcified cartilage for in situ hybridization has been
described previously11. Individual patient samples which
were representative of normal and osteoarthritic cartilage
were analysed. These were distinct from samples used for
cDNA library preparation and Northern blot analysis. cDNA
templates for the partial coding regions of clusterin and
Gal-Nac transferase were prepared by PCR with primers
that included the T7 and SP6 polymerase sites. Riboprobes
were prepared using the Promega (Madison, WI) In vitro
transcription kit with 35S-thio CTP (Amersham Pharmacia
Biotech, Piscataway, NJ). Cryostat sections were collected
onto 3-aminopropyltriethoxy silane-coated slides, fixed in
4% paraformaldehyde, dehydrated and frozen at −20°C
prior to hybridization. For hybridization, sections were
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Partial list of known proteins (GenBank accession in parentheses) encoded by ESTs identified from human
cartilage cDNA libraries
1. Collagens/
Proteoglycans/Matrix Proteins
Alpha-1 type I collagen (NM
–
000088)
Alpha-2 type I collagen (NM
–
00089)
Alpha-1 type II collagen (NM
–
001844)
Type VI collagen (NM
–
004369)
Type IX collagen (NM
–
001853)
Type X collagen (X98568)
Type XI collagen (J04177)
Aggrecan (AF148213)
Decorin (NM
–
001920)
COMP (L32137)
Fibronectin (X02761)
Fibromodulin (NM
–
002023)
Matrix Gla protein precursor (X53331)
Secretory proteoglycan core protein (J03223)
Cartilage intermediate layer protein (CILP) (AB022430)
Vimentin (Z19554)
Laminin (S37431)
Laminin-binding protein (X61156)
Lumican precursor (NM
–
002345)
Fibrinogen (M64982)
Osteonectin (NM
–
003118)
2. Nuclear Proteins
Zinc finger protein 216 (AF062346)
Nucleophosmin (NM
–
006993)
RNA binding protein RNPL (P98179)
Heter. nuclear ribonucleoprotein C (X12517)
Heter. nuclear ribonucleoprotein D1 (NM
–
006938)
Heter. nuclear ribonucleoprotein G (Q15357)
Heter. nuclear ribonucleoprotein K (S74678)
Heter. nuclear ribonucleoprotein R (AF000364)
NF-Kappa-B P65 subunit (M62399)
Nuclear poly(C)-binding protein (X78136)
H1 histone family member (Z97630)
RNA polymerase trans. coactivator P15 (U12979)
Step II splicing factor SLU7 (AF101074)
NHR corepressor SMRT (S60255)
Pre-mRNA splicing factor SF3a (AC004997)
PHD finger protein 1 (AL021366)
3. Oncogenes/Growth
Factors
Translationally controlled tumor protein (X16064)
Mitogen-inducible mig-6 product (AAB35056)
Rho (ras homolog) protein (P97433)
Ras-related protein Rab-1A (M28209)
Insulin-induced growth response protein (Q08755)
RAB28 (ras oncogene family) (NM
–
004249)
Cell cycle protein p38-2G4 (NM
–
006191)
Oncogene TIM (NM
–
005435)
Frezzled (U68057)
FRZB (U24163)
CTGF (NM
–
001901)
CTGF-L (WISP2) (NM
–
003881)
Progenitor B-cell stimulating factor (U02020)
4. Growth Suppressors
NIP3 (apoptosis inducing protein) (Q12983)
BTG-1 (anti-proliferative factor) (X61123)
Putative tumor suppressor ST13 (U17714)
5. Transcription Factors
Transcription factor IIIA (Q92664)
Transcription factor SOX-9 (P48436)
Cyclic AMP transcription factor ATF-4 (P18848)
Transcription factor NRF1 (NM 005011)
Human homolog of chicken Homeobox (AF100755)
Helix-loop-helix protein ID1 (U57645)
Homeobox protein TGIF (X89750)
5. Transcription Factors continued
Adenovirus E1B interacting protein 3A (Af067396)
Zinc finger transcription factor EZF (O43474)
Zinc finger protein 173 (U09825)
6. Receptor/Signaling Proteins
LDL receptor-related protein (AAA56833)
GPCR RDC1 (M64749)
Endothelial cell protein C receptor (NM
–
006404)
TGF-beta receptor type II (M85079)
Onstatin-M specific receptor beta subunit (U60805)
Gi2 protein alpha subunit (M20593)
GTP-binding regulatory protein Gs alpha (M21142)
Possible GTP-binding protein HSR1 (L25665)
GTP-binding protein TC10 (M31470)
Integrin 5 subnunit (X06256)
Integrin 10 subunit (AF074015)
7. Enzymes/Enzyme
Enhancer/Inhibitors
Glutathione peroxidase (Y00433)
MMP3 (NM
–
002422)
Lactate dehydrogenase (Y00711)
Extracellular superoxide dismutase (J02947)
Plasma protease C1 inhibitor (X54486)
Glutathione synthetase (NM
–
000178)
Chitinase precursor (NM
–
001276)
Alpha-1 antitrypsin (X01683)
Fructose biphosphate aldolase (X05236)
Cysteine dioxygenase (D85781)
Nicotinamide-N-methyl transferase (NM
–
006169)
Inducible 6-phosphofructose-2-k inase) (D25328)
Calcium-dependent protease (X04106)
ATP-sulfurylase/APS kinase (AF016496)
ATP-dependent protease, lon protease (P37945)
Glutaminyl-tRNA ligase (X76013)
H+-transporting ATPase (M62762)
RNA helicase (Z37166)
DNA helicase (P12956)
protein phosphatase 2C gamma (Y13936)
MAP-kinase phosphatase (S29090)
Stress-activated protease Omi (AF020760)
NADH-depend. isocitrate dehydrogenase (AF020038)
Pyruvate dehydrogenase kinase (Q16654)
Phosphatidylserine synthase I (P48651)
Seryl-tRNA synthetase (X91257)
Serine hydroxymethyltransfer ase (L23928)
Succinate dehydrogenase (P31040)
Apurinic/apyrimidinic endonuclease (D13370)
Acyl-coenzyme A dehydrogenase (X86556)
RNA polymerase II CTD phosphatase (AF154115)
TIMP-2 (J05593)
TIMP-3 (X76227)
TIMP-4 (U76456)
Sialyltransferase 4A (L13972)
10-formyltetrahydrofo late dehydrogenase (AF052732)
Malate dehydrogenase (Af047470)
N-acylspingosine amidohyrolase (U70063)
SUMO-1 activating enzyme (AF110957)
Protein disulfide isomerase (M22806)
Histidyl-tRNA synthetase (Z11518)
ADP-ribosyltransferas e (M32721)
6-phosphofructokinase type C (Q01813)
Alcohol dehydrogenase (J04794)
Beta-galactosidase alpha (U12390)
3-methyl-2-oxobutanoa te dehydrogenase (P12694)
Cathepsin B (M14221)
8. Ribosomal Proteins
BBC-1 (X64707)
Ribosomal protein S5 (P46782)
Osteoarthritis and Cartilage Vol. 9, No. 7 645hydrated, demineralized and acetylated then hybridized at
42°C for 4 h. Post-hybridization washes were at a final
stringency of 0.1×SSC. Hybridized sections were coated
in LM-1 film emulsion (Amersham Pharmacia Biotech,
Piscataway, NJ), exposed at 4°C for 2 weeks, developed in
Kodak developer and counterstained with methylene blue.
The extent of hybridization signal was assessed by the
autoradiographic grain density over individual cells.ResultsPREPARATION OF CDNA LIBRARIES
Adult human cartilage was collected from patients under-
going knee surgery or at the time of autopsy. Based on
gross pathology and histological examination, the cartilage
tissue was scored as normal or diseased (signs of early
and/or late OA) and pooled separately. High-quality poly A+
RNA from these two tissue pools was used to generate
directional cDNA libraries in the pSPORT1 vector. A total of
1.6×107 and 7×106 independent clones were obtained
from the normal and osteoarthritic cDNA libraries, respect-
ively. An analysis of nineteen randomly selected clones
from each library indicated that these libraries contained anaverage insert size of 1.3–1.5 Kb and the range varied
between 0.3 to 4.2 Kb (Fig. 1). These data suggest that the
two libraries were comparable in terms of size, quality and
diversity of expressed genes.Table II
Continued
8. Ribosomal Proteins continued
Ribosomal protein L21 (P46778)
Ribosomal protein S9 (P46781)
Ribosomal protein A0 (U23803)
9. Immunological
Proteins/Antigens
Complement factor H (P08603)
Complement C1S (J04080)
HLA I histocompatibility antigen E (M20022)
Lympocyte activation antigen 4F2 (J03569)
B7 (U47924)
Breast tumor autoantigen (U24576)
MHC class I antigen (U04245)
Epithelial tumor antigen (M35093)
Paraneoplastic neuronal antigen MA1 (AF037364)
10. Cytoskeletal Proteins
Gamma-actin (X04098)
Actin, cytoplasmic type 8 (P02570)
Actin-like protein 3 (P32391)
Actin-like protein 6 (AB015907)
Glycine-rich protein GIRP (D78134)
Cytoskeletal tropomyosin (X04588)
Gelsolin (actin CL-6 depolymer. factor) (X04412)
11. Other Proteins
Clusterin (complement-assoc. prot. SP-40) (X14723)
Cartilage glycoprotein GP-39 (NM
–
001276)
Dihydroxyvitamin D-3 induced protein (S73591)
Apolipoprotein D (J02611)
Proactivator polypeptide precursor (J03015)
Oxidative stress protein (U46751)
Ferritin heavy chain (M11146)
Prolargin (P51888)
Peripheral myelin protein (L03203)
RNA binding protein CIRP (AF021336)
Annexin II (lipocortin II) (D00017)
Microvascular endothel. differentiat. gene (X98993)
Phosphotyrosine ligand for LCK (U46751)
B-cell translocation gene 1 protein (S20947)
11. Other Proteins continued
Scraple responsive protein (AJ224677)
Glucose regulated protein (M19645)
Macrosialin precursor (A48931)
Amyloid 4A protein precursor (X06989)
Translation factor 4B (S12566)
Erythrocyte adducin alpha subunit (X58141)
Calcium-binding PW29 protein (D38551)
TOB protein (transducer of ERBB-2) (D38305)
Transmembrane protein TMP-21 (AJ004913)
Sorting nexin (degradation of EGFR) (AF034546)
PMS-2 related gene (U38964)
RIL gene (X93510)
ADP-ribosylation factor 1(M84326)
Protein transport prtein SEC23 (X97064)
Suppressor of cytokine signaling-3 (AB006967)
NIFU-like protein (U47101)
Neuritin (AF136631)
Osteomodulin (AB000114)
Mucin core protein 24 precursor (D14043)
Retinitis pigmentosa GTPase regulator (U57629)
Complement component 4-binding protein (M62486)
Prohibitin (S85655)
TGF beta-stimulated protein (Q15714)
Decay-accelerating factor splice form 1 (A26359)
RNA-binding protein alpha-CP1 (U24223)
EGF receptor kinase substrate EPS8 (U12535)
Putative surface glycoprotein C21ORF1 (Z50022)
Eukaryotic translation initiation factor 4A (D13748)
ER translocon component (AF100141)
Tuberous sclerosis protein 2 (A49420)
26S proteosome regulatory subunit S5A (U51007)
Golgi stacking protein homolog GRASP (AF110267)
Cyclin C (U40739)
Putative cyclin G1 interacting protein (AC004876)
Mitochron. membrane translocase TIM23 (AF030162)
Adrenomedullin (D14874)
Kinesin heavy chain (X65873)
Tubulin (K00558)
Phospholipase C-activating G-protein (L40630)
K+ channel, subfamily K, member 1 (AF084830)SEQUENCING AND ANALYSIS OF ESTS
In order to analyse the global gene expression profile in
normal and osteoarthritic cartilage, approximately 5000
random ESTs from each library were sequenced from the 5′
end. To aid in the analysis of expressed genes, overlapping
ESTs corresponding to the same gene were grouped
into assemblies that represented virtual cDNAs. The
assemblies were then compared against public gene data-
bases as described in detail in Materials and methods. Out
of 5226 ESTs sequenced from the normal cartilage library,
4415 were grouped into 2819 assemblies. In normal carti-
lage, a total of 119 (4%) and 1110 (40%) assemblies
were novel homologs and unknown, respectively (Table I).
Similarly, 5023 ESTs were sequenced from the osteo-
arthritic cartilage library and 4085 were grouped into 2337
assemblies. The number of novel homologs and unknown
assemblies were 139 (6%) and 666 (28%), respectively in
osteoarthritic cartilage (Table I). Together, these data
646 S. Kumar et al.: Preparation, sequencing and analysis of cDNA libraries from normal and OA cartilageindicate that there are large numbers of undescribed pro-
teins (either unknowns or novel homologs) within articular
cartilage.ANALYSIS OF KNOWN GENES
An analysis of assembled ESTs from both libraries
indicated that approximately half (56–66%) of the assem-
blies correspond to known genes (>95% identity over
50 bps, see Materials and methods and Table I). A partial
combined list of these genes (with corresponding GenBank
accession numbers) from both normal and osteoarthritic
cartilage libraries is shown in Table II. A diverse array of
gene families is represented in cartilage, suggesting a
highly dynamic and metabolically active nature of cartilage
tissue. These include matrix proteins, growth factors/
growth suppressors, nuclear proteins, signaling molecules,
enzymes, enzyme inhibitors, ribosomal proteins and pro-
teins involved in the immune system. Approximately 10% of
the known sequenced assemblies (5–6% of the total
assemblies) code for genes reported to be highly
expressed in cartilage tissue (Tables II and III). These
include aggrecan, collagens, decorin, cartilage oligomeric
matrix protein (COMP), fibromodulin, vimentin, fibronectin
and many others (Table II). Although these genes are also
expressed in some other tissues, their presence supports
the authenticity of the tissue used for the preparation of the
cDNA libraries.Table III
List of 20 most abundant genes in human adult normal and osteoarthritic cartilage cDNA libraries
Rank Normal cartilage Accession No. of
ESTs
OA cartilage Accession No. of
ESTs
1 Decorin M14219 174 Decorin M14219 190
2 Plasma glutathione peroxidase D00632 140 COMP L32137 127
3 Clusterin J02908 71 Plasma glutathione peroxidase D00632 126
4 MMP-3 X05233 40 Clusterin J02908 96
5 Apolipoprotein D precursor J02611 40 Fibronectin A14133 60
6 Vit D3-upregulated gene S73591 30 CTGF X78947 56
7 Vimentin X56134 27 HC-gp39 M80927 45
8 Fibronectin A14133 25 Proline arginine-rich end leucin-rich
repeat protein
U29089 44
9 COMP L32137 24 Vimentin X56134 31
10 Complement factor H Y00716 24 Aggrecan M55172 28
11 Tumor protein translationally
controlled
X16064 24 Extracellular Superoxide Dismutase-3 A12573 27
12 TSC22-like protein AF183393 22 MMP-3 X05233 26
13 HC-gp39 M80927 22 Apolipoprotein D precursor J02611 24
14 Matrix gla protein precursor M55270 22 Fibromodulin precursor U05291 21
15 Aggrecan M55172 18 Alpha 1-antichymotrypsin AF089747 15
16 Alpha 1-antichymotrypsin AF089747 15 Complement factor H Y00716 15
17 CTGF X78947 14 Gal-Nac transferase AY035399 14
18 Proline arginine-rich end leucin-rich
repeat protein
U29089 13 Plasma protease C1 inhibitor M13656 14
19 Extracellular Superoxide Dismutase-3 A12573 12 Saposin precursor D00422 14
20 Lumican G28583 12 TSC22-like protein AF183393 14
For each gene, the ranking within a library, GenBank accession number and number of corresponding ESTs are provided.ANALYSIS OF TOP 20 MOST ABUNDANTLY EXPRESSED GENES
Based on an analysis of ESTs and their assembled
sequences, we generated a list of the 20 most abundantly
expressed genes in both the normal and osteoarthritic
cDNA cartilage libraries. This list, with the number of ESTscorresponding to each gene, is shown in Table III. The
genes from both libraries represented several unique
classes of proteins, including matrix proteins, complement
proteins, anti-oxidant enzymes, proteinases and proteinase
inhibitors. The total number of ESTs for a given gene
ranged from 174 to 190 ESTs for decorin to 12 and 14 ESTs
for lumican and TSC-22-like protein, respectively. The
pattern of the most abundantly expressed genes in normal
and osteoarthritic cartilage libraries is not identical, sug-
gesting a change in gene expression profile during disease
progression. While decorin appears to be the most abun-
dantly expressed gene in both normal and osteoarthritic
cartilage, there are several genes which show varying
levels of expression. For example, fibromodulin, plasma
protease C1, and saposin are among the top 20 most
abundant genes expressed in the osteoarthritic cartilage
but not in the normal cartilage library. Similarly, Vitamin D3
upregulated gene, matrix gla protein and lumican are highly
abundant in the normal cartilage but not in the osteoarthritic
cartilage library (Table III). Several of these genes have
been described using biochemical and/or immunochemical
analysis of human articular cartilage, including CTGF12,
fibronectin13, aggrecan14, decorin15, HCgp3916, COMP17,
vimentin18, and lumican19 and are present in both libraries,
albeit at varying levels. A small number of assemblies
within these top 20 genes code for proteins that are well
characterized, but whose expression has not yet been
described in articular cartilage. These include plasma
glutathione peroxidase, clusterin, translationally controlled
tumor protein, TSC22-like protein, and complement factor
H (Table III). These data indicate that, in addition to the
unknown and novel homologs described above, there are a
large number of genes expressed at high levels in articular
cartilage that have not been previously described in this
tissue using protein biochemical approaches. It is possible
that the corresponding protein products are expressed at
Osteoarthritis and Cartilage Vol. 9, No. 7 647relatively low levels or have relatively short half-lives within
the tissue and, consequently, that biochemical approaches
may not be sensitive enough to detect these molecules.ANALYSIS OF NOVEL HOMOLOGS OF KNOWN GENES
A comparison of assemblies to the GenBank database
as well as protein motif searches revealed that approxi-
mately 4–6% of the assemblies are novel homologs of
known genes (BLAST P-value ≤1×10−6, see Materials and
methods). A partial list of these novel genes is presented in
Table IV. Several different classes of genes were identified
that encode matrix proteins (biglycan and perlecan), tran-
scription factors (NF-B, p52 subunit, kruppel-like zinc
finger protein), enzymes (Gal-Nac transferase, protein tyro-
sine phosphatase, ATPase), and several KIAA proteins that
are present in the database as putative proteins translated
from open reading frames generated by large scale
sequencing. We have selected and examined the tissue
distribution of two of these novel homologs, PCPE-2 andGal-Nac transferase, and confirmed their expression in
cartilage tissue as described below. Interestingly, novel
Gal-Nac transferase is the seventeenth most abundantly
expressed gene in the OA library by EST analysis (14
ESTs, Table II). In contrast, there are a total of nine ESTs
from the osteoarthritic and one EST from the normal
cartilage library for PCPE-2, but it is not among the top 20
most abundantly expressed genes in either library.CONFIRMATION AND CHARACTERIZATION OF GENE EXPRESSION
OF KNOWN GENES NOT PREVIOUSLY DESCRIBED IN HUMAN
ARTICULAR CARTILAGE
As described above, a large number of known genes
were expressed in either the normal or the osteoarthritic
cartilage (Table III), several of which had not been pre-
viously described in cartilage. Three of the known genes,
connective tissue growth factor (CTGF), CTGF-like
(CTGF-L) and clusterin were chosen for further analysis
using Northern blotting, and in some cases, in situ hybridi-
zation. This allows for evaluation of expression patterns
within multiple cells and/or tissues as well as identification
of the transcript size of the gene of interest.
CTGF is a gene involved in wound healing and fibrosis
and has been reported to be expressed in hypertrophic
chondrocytes in cartilage20,21. As suggested by the library
sequencing, CTGF is one of the top 20 most abundant
genes expressed in both normal (seventeenth) and osteo-
arthritic (sixth) cartilage libraries (Table IV). Consistent with
EST data, a transcript of ∼2.4 Kb20 corresponding to CTGF
was easily detected in human cartilage samples by
Northern blot analysis. CTGF was detected in two of four
control and three of four osteoarthritic cartilage samples
[Fig. 2(a)].
CTGF-L, a homolog of CTGF, was chosen for further
analysis based on a recent report of its high expression in
bone22. Low levels of CTGF-L were detected in seven of
eight cartilage samples by Northern blot analysis with the
expected transcript size of ∼1.4 Kb. Significant expression
was observed in only one of the normal cartilage samples,
as shown in Fig. 2(a). Interestingly, although CTGF-L is
expressed at a lower level than CTGF, the expression of
the two genes parallels each other.
Lastly, clusterin is a protein which may play a protective
role in cells under stress23. Clusterin is also one of the most
abundantly expressed genes by EST analysis in both
normal and osteoarthritic cartilage libraries (Table III). Its
abundance in cartilage was confirmed by Northern blot
analysis where significant expression was detected in all
control and osteoarthritic cartilage samples tested [Fig.
2(a)]. In contrast, in situ hybridization revealed that
clusterin gene expression was upregulated in chondrocytes
in cartilage with early OA changes [Fig. 2(b)] and
was reduced with advanced OA disease [Fig. 2(c), (d)].
Confirmation by Northern and in situ hybridization analysis
of genes suggested by EST/assembly analysis validates
the EST analysis of libraries as a powerful approach
for identification of novel or known genes that have not
previously been reported to be expressed in cartilage.Table IV
Partial list of novel gene homologs identified from adult human
normal and osteoarthritic cartilage cDNA libraries
Procollagen C-proteinase enhancer protein-2 (PCPE-2)
N-acetylgalactosoaminylamine transferase homolog (Gal-Nac
transferase)
Protein tyrosine phosphatase
B cell-growth factor
Biglycan
Perlecan
Laminin-like adhesion protein homolog
NADH-ubiquinone oxidoreductase MLRQ subunit homolog
Transporter protein homolog
NF-B homolog, p52 subunit
Na+ transporter
Sugar transporter
Kruppel-like (rodent) transcriptor factor human homolog
Peroxisomal D2,D4-dienoyl-coA reductase (rodent) human
homolog
SREBP-2 leucine zipper transcription factor homolog
Zinc finger protein ZNF139 homolog
Human lympocyte specific formin related protein
Human HL-60 induced differentiation immediate early protein
ETR101 homolog
Hemicentin homolog
Zinc finger protein
Phosphate uptake stimulating protein homolog
Putative transcription factor CR53 homolog
Putative ATPase homolog
Zinc finger protein ZID homolog
Chromosome condensation protein homolog
K+/Na+ co-transporter
Alpha 1,3-fucosyltransferase
Fidipidine (Drosophila) human homolog
TRAB protein (E. Coli) human homolog
Nucleotide pyrophosphohydrolase
Histone deacetylase
Echinoderm microtubule-associated protein homolog
Coagulation factor C homolog
Mannosyl-oligosaccacharide alpha-1,2-mannosidase homolog
Peroxidase
Zinc finger protein 83 homolog
Slit protein-2 (Drosophila) human homolog
Laminin-beta-2 homolog
JM2 homolog
KIAA0025, 0055, 0058, 0075, 0081
KIAA0375, 0381, 0456, 0682
KIAA0899, 1049CONFIRMATION AND CHARACTERIZATION OF GENE EXPRESSION
OF NOVEL HOMOLOGS OF KNOWN GENES NOT PREVIOUSLY
DESCRIBED IN HUMAN ARTICULAR CARTILAGE
In addition to known genes, several novel homologs of
known genes (BLAST P-value ≤10−6, see Materials and
648 S. Kumar et al.: Preparation, sequencing and analysis of cDNA libraries from normal and OA cartilageFig. 2. Expression of CTGF, CTGF-L and clusterin in cartilage. (a) A Northern blot containing total RNA from four different normal and
osteoarthritic cartilage donors was hybridized sequentially with various 32[P]-labeled cDNA probes. The blot was stripped between each
hybridization. The location and size of each mRNA is indicated. (b)–(d). Cryostat sections of human articular cartilage with early OA (b) and
advanced OA (c), (d) were hybridized with 35S-labeled clusterin antisense riboprobe and counterstained with methylene blue. Clusterin
mRNA was expressed at high levels in chondrocytes throughout the superficial and mid-zones in cartilage with early OA [(b) arrowheads].
In contrast, cloning chondrocytes from advanced osteoarthritic cartilage (c) showed low levels of clusterin mRNA expression (arrowheads).
Magnification ×200. Inset (d) shows a cloning chondrocyte. Magnification ×400.
Osteoarthritis and Cartilage Vol. 9, No. 7 649methods) were identified that had not previously been
reported in articular cartilage (Table IV). Two of these novel
gene homologs, procollagen C-proteinase enhancer
protein-2 (PCPE-2) and novel Gal-Nac transferase, were
chosen for further analysis. Since these are novel genes
that have not been described previously, the tissue
distribution analysis was extended to include multiple tis-
sue Northern blots, in addition to RNA from normal and
osteoarthritic cartilage.
We have identified PCPE-2 as a novel homolog of
human PCPE (PID accession # gi/2589011, 46.3% identity
over the entire protein)24. PCPE is known to enhance bone
morphogenetic protein 1 (BMP1) or PCP processing of the
C-terminus of types I, II and III collagens25. A transcript
of ∼2 Kb corresponding to PCPE-2 is highly expressed
in normal and osteoarthritic cartilage. Its expression was
also detected in heart, kidney, placenta and MG 63
(osteosarcoma) cells (Fig. 3).
Another novel gene, Gal-Nac-transferase, is a homolog
of UDP-N-acetyl galactosaminyltransferase. It may be
involved in O-linked glycosylation of proteoglycans synthe-
sized by chondrocytes26. The novel Gal-Nac transferase
polypeptide is related to human polynucleotide Gal-
Nac transferase-T4 (ppGaNtase-T4, PID Accession #
NP
–
003765, 60.74% identity over 135 aa in the catalytic
domain and 47.2% identity over the entire protein)27. It is
expressed rather selectively in both normal and osteoar-
thritic cartilage and SaOS2 (osteosarcoma) cells [Fig. 4(a)]
and not in any other human tissue represented on the
multiple tissue Northern blot (not shown). It is expressed in
all three osteoarthritic cartilage samples; one of the normal
cartilage samples shows extremely high level expression.
By in situ hybridization, this gene was expressed at low
levels in chondrocytes in all zones of both normal [Fig. 4(b)]
and osteoarthritic cartilage [Fig. 4(c), (d)]. Based on its
expression within articular cartilage and its homology to
other Gal-Nac transferases, this protein may play a role in
glycosaminoglycan processing in human articular cartilage.Further analysis and functional characterization is required
to elucidate the role of these novel homologs in articular
cartilage.Fig. 3. Expression of PCPE-2 in various human cells and tissue by Northern blot analysis. A Northern blot containing total RNA from various
tissues and normal and osteoarthritic cartilage as indicated were hybridized with 32[P]-labeled PCPE-2 and GAPDH cDNA probes. The
location and size of each mRNA is indicated. Sk. Mus., skeletal muscle; Sm. Int., small intestine; PBLs, peripheral blood mononuclear cells.
SaOS2, HOS and MG63 cells are osteosarcoma cells and TF-274 is a stromal cell line.Discussion
Due to the difficulty in obtaining well-characterized
human articular cartilage as well as its complex biochemi-
cal nature, it has been difficult to evaluate large scale gene
expression analysis in normal and osteoarthritic human
cartilage tissue. In this paper, we report, for the first time,
the preparation, sequencing and analysis of adult human
normal and osteoarthritic cartilage cDNA libraries. Several
cartilage proteins that have been identified biochemically
were also identified by sequence analysis of our libraries.
Detailed analysis of ESTs suggest that a diverse array of
gene families are expressed in cartilage and indicates the
dynamic and metabolically active nature of cartilage tissue,
even in individuals with osteoarthritic disease. This
approach has also resulted in not only the identification of a
large number of known genes not previously described
in articular cartilage, but also novel gene homologs and
a variety of, as yet, undescribed genes. The fact that a
significant proportion of the sequences codes for unknown
genes suggests that the biochemical characterization of
cartilage, which has been reported to date, has only begun
to describe the complexity of this tissue. A large focused
effort will be required to determine the precise function of
each of these homologs or unknown genes.
The libraries described in this manuscript were prepared
from RNA isolated directly from human articular cartilage
without any subculture or amplification. This approach was
used to prepare libraries that most closely reflect expres-
sion within the tissues at the time of isolation, without
introducing the potential complication of amplification arte-
facts. In these libraries, the expression levels of a large
650 S. Kumar et al.: Preparation, sequencing and analysis of cDNA libraries from normal and OA cartilageFig. 4. Expression of novel Gal-Nac-transferase in various human cells and cartilage by Northern blot and in situ hybridization analysis. (a)
A Northern blot containing total RNA from various cells and from normal and osteoarthritic cartilage as indicated was hybridized with
32[P]-labeled novel Gal-Nac-transferase and GAPDH cDNA probes. The location and size of each mRNA is indicated. SaOS2, HOS and
MG63 cells are osteosarcoma cells and TF-274 is a stromal cell line. (b)–(d) Cryostat sections of human normal (b) and advanced OA (c),
(d) articular cartilage were hybridized with 35S-labeled novel Gal-Nac-transferase antisense riboprobe and counterstained with methylene
blue. Novel Gal-Nac-transferase mRNA was expressed at low levels in chondrocytes throughout the superficial and mid-zones of normal
cartilage [(b) arrowheads]. Magnification ×200. It was expressed at low levels in cloning chondrocytes of cartilage with advanced OA [(c)
arrowhead]. Magnification ×200. Inset (d) shows a cloning chondrocyte. Magnification ×400.number of genes appear very low, as they are represented
by only a few or often by a single EST. It is not clear if such
low level of expression is functionally relevant. Additional
in-depth sequencing will provide answers to this question.To begin to understand function, the expression pattern of
these genes first needs to be compared using additional
approaches such as Northern blotting and in situ hybridiza-
tion. If confirmed, further evaluation of protein expression
Osteoarthritis and Cartilage Vol. 9, No. 7 651patterns by quantitative and biochemical analyses would
be required.
The libraries were generated from pooled cartilage
samples; therefore, significant patient to patient variation in
the expression pattern of any one gene may be masked.
This was especially true for the osteoarthritic cartilage,
which represented an entire range of disease severity, from
early to advanced stages. Finally, the focal nature of the
osteoarthritic lesions on the joint surfaces creates another
challenge to meaningful interpretation of pooled, extracted
tissue samples. Northern analysis of individual patient
cartilage RNA provides global validation of gene expres-
sion in the entire tissue and relative abundance between
patient samples. This is especially useful where genes are
expressed at a low level in all cells. By contrast, Northern
blot analysis will not detect gene expression in a few select
cells of a tissue nor will it distinguish expression patterns
between zones of cartilage. In situ hybridization provides
detailed expression analysis and comparison between
chondrocytes in various zones; however, it will not detect
very low level expression. Using a combination of
approaches, the expression pattern of a select number of
genes was further evaluated in this study.
Many matrix components such as aggrecan, types II, IX
and X collagens, decorin, biglycan and fibronectin that
have been described in human articular cartilage were also
found through the library sequencing effort. In addition,
there has been a large focus on the characterization of
proteolytic enzymes within articular cartilage. Sequencing
data supports the high level expression of matrix
metalloproteinase-3 (stromelysin) which is also among the
20 most abundantly expressed genes in the libraries
sequenced. In addition, TIMPs-2, 3, and 4 were also found
but genes encoding aggrecanase or other MMPs such as
MMP-2 and MMP-9 and TIMP-1 were not detected in the
libraries. It is possible that these sequences were not
expressed in the cartilage samples used to prepare the
libraries or that further sequencing is needed to identify
genes expressed at low levels. This points to one of the
drawbacks of limited sequencing using a small number of
pooled samples for library preparation and indicates that
confirmation of the expression obtained through library
sequencing using other approaches is necessary.
Type II collagen is one of the most abundant and key
structural proteins in articular cartilage. Based on library
sequencing, type II collagen is expressed at extremely low
levels within both the control and osteoarthritic cartilage
samples. Consistent with the library analysis data, the
expression of type II collagen was found to be very low by
Northern blot analysis of adult normal and osteoarthritic
cartilage (data not shown). This is consistent with the
extremely long half-life of this protein, which has been
suggested to be several years28. Type II collagen expres-
sion has been reported to be low in control tissue but
elevated in tissue shortly after joint trauma29. The level of
expression of this protein may then decrease as the dis-
ease progresses. Since the cartilage samples were pooled
from early and advanced osteoarthritic cartilage, detection
of transient changes in gene expression may be lost when
one examines expression through analysis of EST abun-
dance. Analysis by in situ hybridization may be required to
detect such fine level of control. This is similar to results
obtained with clusterin where EST abundance was similar
for normal and osteoarthritic cartilage whereas elevated
expression in early OA and reduced expression in
advanced OA was only revealed when individual, carefully
characterized, cartilage tissues were examined30.It was of interest to note the presence of anti-oxidant
enzymes such as glutathione peroxidase and superoxide
dismutase in the cartilage libraries. The role of oxygen
intermediates in arthritic cartilage matrix degradation has
been proposed. It has been demonstrated that articular
chondrocytes are capable of producing hydrogen per-
oxide31 and it has been proposed that free-radicals may
contribute to depolymerization of hyaluronic acid and even
possibly proteoglycan breakdown with disease progres-
sion. Glutathione peroxidase was expressed at very high
levels in both the normal and osteoarthritic cartilage cDNA
libraries. The role of glutathione peroxidase in protection
against oxidative stress in articular cartilage has been
characterized in association with Kashin-Beck disease,
a chronic osteoarthritic condition32. Additionally, Tschan
et al.33 have reported that cysteine-like anti-oxidants are
required for the survival of rat and chicken chondrocytes
in culture. The induction of anti-oxidant enzymes in the
arthritic disease process may be an attempt by the
chondrocytes to defend against damage.
A role for complement proteins in cartilage matrix degra-
dation has also been proposed34 and the capacity of
chondrocytes to produce complement proteins has been
demonstrated35. Several complement cascade genes were
present in the cDNA libraries including complement factor
H and complement C1s. Inhibition of the complement
cascade would be an important mechanism for protection
of the cartilage from degradation. Clusterin, which was
highly expressed in the cartilage, is a known inhibitor of the
terminal complement assembly36. The expression of
decay-accelerating factor, also found in cartilage libraries,
may provide a homeostatic mechanism by preventing the
formation or dissociation of C3 convertases37.
A large number of growth factors were also detected
through EST analysis. Chondrocytes clearly have the
capacity to both proliferate and produce new matrix when
cultured in vitro. It is currently unclear which proteins may
control matrix production in vivo in cartilage; however, it
seems likely that this control may be mediated through
growth factors. Indeed several genes encoding growth
factors and more importantly growth factor receptors were
found in both libraries. One of the growth factors found in
these libraries is CTGF. It belongs to the CCN (Cyr61,
CTGF, Nov) family of proteins that are involved in various
cellular processes such as cell adhesion, mitogenesis, and
cell matrix interactions and is believed to act downstream of
TGF-. CTGF has been shown to be expressed in human
chondrocytic cell lines21,38. A related family member, Cyr61
has been shown to be expressed during chondrogenesis in
mouse embryo39. CTGF is the seventeenth and sixth most
abundantly expressed gene in the normal and osteoarthritic
cartilage cDNA libraries, respectively. A novel member of
this family of proteins, CTGF-L, has been shown to be
highly expressed in bone and is also expressed in cartilage
albeit at lower levels. CTGF-L has been shown to modulate
osteoblast and chondrocyte functions22.
In addition to the variety of known genes, a number of
novel homologs and unknown gene sequences were also
identified through library sequencing. Homologs are
defined as sequences which have significant similarity
(BLAST P-value ≤1×10−6) to genes encoding known pro-
teins. Since many proteins are members of large protein
families, which are functionally similar, it is possible that
these homologs may have functions similar to their known
counterparts. Again, the true function of these proteins will
only be defined after extensive biochemical and biological
analyses are complete. One of the novel homologs,
652 S. Kumar et al.: Preparation, sequencing and analysis of cDNA libraries from normal and OA cartilagePCPE-2, is a protein related to PCPE which acts as an
enhancer for BMP1 during the processing of collagen types
I-III. C-terminal processing of fibrillar collagen is essential
for proper molecular packaging. Since cartilage is made up
mainly of collagen type II and PCPE-2 is expressed in
cartilage, it is possible that PCPE-2 is involved in the
processing of type II collagen in cartilage. However,
PCPE-2 expression is not restricted to cartilage as its
mRNA was also expressed in heart, kidney, placenta and
MG63 osteosarcoma cell line.
We have also identified a novel Gal-Nac transferase
which may be involved in O-linked transfer of N-acetyl
galactosamine to proteoglycans. It is rather selectively
expressed in cartilage tissue as we could not detect its
mRNA expression in any other tissue represented on a
commercial multiple tissue Northern blot. It is however
expressed in the osteosarcoma cell line, SAOS2. Several
recent studies have indicated that there are significant
glycosaminoglycan changes, which take place on the pro-
teoglycans in aging cartilage and in tissues from patients
with OA40. It is possible that specific enzymes such as
novel Gal-Nac transferase may play a role in the post-
translational modification of proteins.
In summary, these data indicate that in-depth sequenc-
ing of human normal and diseased cartilage cDNA libraries
can be used to identify novel genes that may play a role
in altered cartilage structure. Comparing expression
abundance of genes between normal and osteoarthritic
cartilage libraries may identify potential markers to aid in
the diagnosis of OA. Similarly, identification of genes
involved in cartilage matrix formation and breakdown may
provide therapeutic targets for the treatment of cartilage
diseases.Acknowledgments
The authors wish to acknowledge the bioinformatic and
computing group at GlaxoSmithKline for bioinformatic sup-
port, Annalisa Hand and Salvatore Vitelli for technical
support, David Rieman for critical reading of the manuscript
and Wendy Crowell and Barbara Abrams for preparation of
art work and figures.
The EST sequences reported in this paper have been
submitted to the dBEST database under accession num-
bers 8690315-8695538 for normal and 8675379-8680397
for OA cartilage, respectively and to the GenBankY data-
base under accession numbers BG924211-BG929434 for
normal and BG896161-BG901179 for OA cartilage,
respectively. The full length nucleotide sequence of novel
Gal-Nac transferase and PCPE-2 have been submitted to
the GenBank database under accession numbers
AY035399 and AY035400.References
1. Lawrence RC, Hochberg MC, Kelsey JL, McDuffie FC,
Medsger TAJ, Felts WR, et al. Estimates of the
prevalence of selected arthritic and musculoskeletal
diseases in the United States. J Rheumatol 1989;
16:427–41.
2. Lohmander LS. Molecular markers of cartilage
turnover. In: Kuettner KE, Schleyerbach R, Peyron
JG, Hascall VC, Eds. Articular Cartilage and
Osteoarthritis. New York: Raven Press 1991:653–67.3. Lorenzo P, Bayliss MT, Heinegard D. A novel cartilage
protein (CILP) present in the mid-zone of human
articular cartilage increases with age. J Biol Chem
1998;273:23463–8.
4. Neame PJ, Sommarin Y, Boynton RE, Heinegard D.
The structure of a 38-kDa leucine-rich protein
(chondroadherin) isolated from bovine cartilage. J
Biol Chem 1994;269:21547–54.
5. Tortorella MD, Burn TC, Pratta MA, Abbaszade I, Hollis
JM, Liu R, et al. Purification and cloning of
aggrecanase-1: a member of the ADAMTS family of
proteins. Science 1999; 284:1664–6.
6. Abbaszade I, Liu RQ, Yang F, Rosenfeld SA, Ross OH,
Link JR, et al. Cloning and characterization of
ADAMTS11, an aggrecanase from the ADAMTS
family. J Biol Chem 1999;274:23443–50.
7. Goldring MB, Birkhead JR, Suen L-F, Yamin R, Mizuno
S, Glowacki J, et al. Interleukin-1-modulated gene
expression in immortalized human chondrocytes. J
Clin Invest 1994;94:2307–16.
8. Ragan PM, Badger AM, Cook M, Chin VI, Gowen M,
Grodzinsky AJ, et al. Down-regulation of chondrocyte
aggrecan and type-II collagen gene expression
correlates with increases in static compression mag-
nitude and duration. J Orthopaedic Res 1999;17:
836–42.
9. Okihana H, Yamada K. Preparation of a cDNA library
and preliminary assessment of 1400 genes from
mouse growth plate cartilage. J Bone Miner Res
1999;14:304–10.
10. Adams ME, Huang DQ, Yao LY, Sandell LJ. Extraction
and isolation of mRNA from adult articular cartilage.
Anal Biochem 1992;202:89–95.
11. Dodds RA, Connor JR, James IE. The application of
immunocytochemistry and in situ hybridization to
cryostat sections of undecalcified bone. In: Arnett TR,
Henderson B, Eds. Methods in Bone Biology.
London: Chapman and Hall 1998:198–228.
12. Brigstock DR. The connective tissue growth factor/
cysteine-rich 61/nephroblastoma overexpressed
(CCN) family. Endocrinol Rev 1999;20:189–206.
13. Homandberg GA, Wen C, Hui F. Cartilage damaging
activities of fibronectin fragments derived from
cartilage and synovial fluid. Osteoarthritis Cart 1998;
6:231–44.
14. Doege KJ, Sasaki M, Kumura T, Yamada Y. Complete
coding sequence and deduced primary structure of
the human cartilage large aggregating proteoglycan,
aggrecan. Human-specific repeats, and additional
alternatively spliced forms. J Biol Chem 1991;266:
894–902.
15. Rosenberg LC, Choi HU, Tang L-H, Johnson TL, Pal S,
Webber C, et al. Isolation of dermatan sulfate proteo-
glycans from mature bovine articular cartilages. J
Biol Chem 1985;260:6304–13.
16. Connor JR, Dodds RA, Emery J, Kirkpatrick R,
Rosenberg M, Gowen M. Human cartilage glyco-
protein 39 (HC gp-39) mRNA expression in adult and
fetal chondrocytes, osteoblasts and osteocytes by
in situ hybridization. Osteoarthritis Cart 2000;8:87–
95.
17. Di Cesare PE, Fang C, Leslie MP, Della Valle CJ, Gold
JM, Tulli H, et al. Localization and expression of
cartilage oligomeric matrix protein by human rheu-
matoid and osteoarthritic synovium and cartilage. J
Orthopaedic Res 1999;17:437–45.
Osteoarthritis and Cartilage Vol. 9, No. 7 65318. Aigner T, Loos S, Muller S, Sandell LJ, Unni KK,
Kirchner T. Cell differentiation and matrix gene
expression in mesenchymal chondrosarcomas. Am J
Pathol 2000;156:1327–35.
19. Grover J, Chen X-N, Korenberg JR, Roughley PJ. The
human lumican gene. Organization, chromosomal
location, and expression in articular cartilage. J Biol
Chem 1995;270:21942–9.
20. Bradham DM, Igarashi A, Potter RL, Grotendorst GR.
Connective tissue growth factor: a cysteine-rich
mitogen secreted by human vascular endothelial
cells is related to the SRC-induced immediate early
gene product CEF-10. J Cell Biol 1991;114:1285–94.
21. Nishida T, Nakanishi T, Asano M, Shimo T, Takigawa
M. Effects of CTGF/Hcs24, a hypertrophic
chondrocyte-specific gene product, on the prolifer-
ation and differentiation of osteoblastic cells in vitro. J
Cell Physiol 2000;184:197–206.
22. Kumar S, Hand AT, Connor JR, Dodds RA, Ryan PJ,
Trill JJ, et al. Identification and cloning of a connec-
tive tissue growth factor-like cDNA from human
osteoblasts encoding a novel regulator of osteoblast
functions. J Biol Chem 1999;274:17123–31.
23. Viard I, Wehrli P, Jornot L, Bullani R, Vechietti J-L,
Schifferli JA, et al. Clusterin gene expression medi-
ates resistance to apoptotic cell death induced by
heat shock and oxidative stress. J Invest Dermatol
1999;112:290–6.
24. Hirahara I, Syoufuda K, Harada K, Tomita M, Urakami
K, Terai H, et al. Smooth muscle cell derived procol-
lagen C-protease enhancer protein. Cell Struct Funct
1996;21:661–2.
25. Takahara KE, Kessler E, Biniaminov L, Brusel M, Eddy
RL, Jani-Sait S, et al. Type I procollagen COOH-
terminal proteinase enhancer protein: identification,
primary structure, and chromosomal localization of
the cognate human gene (PCOLCE). J Biol Chem
1994;269:26280–5.
26. Clausen H, Bennet EP. A family of UDP-GalNAc:
polypeptide N-acetylgalactosaminyl-transferase con-
trol the initiation of mucine-type O-linked glyco-
sylation. Glycobiol 1996;6:635–46.
27. Bennett EP, Hassan H, Mandel U, Mirgorodskaya E,
Roepstorff P, Burchell J, et al. Cloning of a human
UDP-N-acetyl-alpha-D-Galactosamine: polypeptide
N- acetylgalactosaminyl-transferase that comple-
ments other GalNAc-transferases in complete
O-glycosylation of the MUC1 tandem repeat. J Biol
Chem 1998;273:30472–81.
28. Maroudas A. Physicochemical properties of articu-
lar cartilage. In: Freeman MAR, Ed. AdultArticular Cartilage. Tunbridge Wells: Pitman Medical
Publishing 1980:30–54.
29. Aigner T, Sto H, Weseloh G, Zeiler G, von der Mark K.
Activation of collagen type II expression in osteo-
arthritic and rheumatoid cartilage. Virchows Archiv B
Cell Pathol 1992;62:337–45.
30. Connor JR, Kumar S, Sathe S, Mooney J, O’Brien SP,
Mui P, et al. Clusterin expression in adult human
normal and osteoarthritic articular cartilage. Osteo-
arthritis and Cartilage 2000 (in press).
31. Tiku ML, Liesch JB, Robertson FM. Production of
hydrogen peroxide by rabbit articular chondrocytes.
J Immunol 1990;145:690–6.
32. Peng A, Yang C, Rui H, Li H. Study on the patho-
genic factors of Kashin-Beck disease. J Toxicol
Environmental Health 1992;35:79–90.
33. Tschan T, Hoeler I, Houze Y, Winterhalter KH, Richter
C, Bruckner P. et al. Resting chondrocytes in culture
survive without growth factors, but are sensitive to
toxic oxygen metabolites. J Cell Biol 1990;111:257–
60.
34. Moskowitz RW, Kresina TF. Immunofluorescent
analysis of experimental osteoarthritc cartilage and
synovium: evidence for selective deposition of immu-
noglobulin and complement in cartilaginous tissues.
J Rheumatol 1986;13:391–6.
35. Andrades JA, Nimni ME, Becerra J, Eisenstein R,
Davis M, Sorgente N. Complement proteins are
present in developing endochondral bone and may
mediate cartilage cell death and vascularization. Exp
Cell Res 1996;227:208–13.
36. McDonald JF, Nelsestuen GL. Potent inhibition of
terminal complement assembly by clusterin: charac-
terization of its impact on C9 polymerization.
Biochemistry 1997;36:7464–73.
37. Shenoy-Scaria AM, Kwong J, Fujita T, Olszowy MW,
Shaw AS, Lublin DM. Signal transduction through
decay-accelerating factor. J Immunol 1992;149:
3535–41.
38. Nishida T, Nakanishi T, Shimo T, Asano M, Hattori T,
Tamatani T, et al. Demonstration of receptors specific
for connective tissue growth factor on a human
chondrocytic cell line (HCS-2/8). Biochem Biophys
Res Comm 1998;247:905–9.
39. O’Brien TP, Lau LF. Expression of the growth
factor-inducible immediate early gene cyr61 corre-
lates with chondrogenesis during mouse embryonic
development. Cell Growth Differ 1992;3:645–54.
40. Plaas AHK, West LA, Wong-Palms S, Nelson FRT.
Glycosaminoglycan sulfation in human osteoarthritis.
J Biol Chem 1998;273:12642–49.
